尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by O'Connor Donal, 董事. Director active across 2 companies, notably PERRIGO Co plc. In total, 11 filings have been published. Activity tracked since 7 May 2021. The latest transaction was filed on 14 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Donal O'Connor is a Board Member at Perrigo Co plc and Theravance Biopharma, Inc. In these roles, he participates in the governance and strategic decision-making of the companies. Donal contributes to policy development and strategic direction, ensuring that the companies meet their objectives while adhering to ethical and compliance standards. His experience is a valuable asset to the boards.